Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Acq. announced
Appointed director
Upcoming conference date
PRAECIS PHARMACEUTICALS INC (PRCS) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2007 8-K Quarterly results
02/16/2007 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
02/16/2007 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
02/15/2007 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
02/13/2007 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2007 4 SHARROCK DAVID B (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Unknown transaction of 12,750 shares @ $5, valued at $63.8k
Disposed/sold 4,000 options to buy @ $4.08, valued at $16.3k
02/09/2007 SC 13G/A DIMENSIONAL FUND ADVISORS INC reports a 6.5% stake in PRAECIS PHARMACEUTICALS INC
02/08/2007 4 ZENNER PATRICK J (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Disposed/sold 4,000 options to buy @ $4.08, valued at $16.3k
02/08/2007 4 POST LEONARD E (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Disposed/sold 4,000 options to buy @ $4.08, valued at $16.3k
02/08/2007 4 MCCANCE HENRY F (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Unknown transaction of 14,054 shares @ $5, valued at $70.3k
Disposed/sold 4,000 options to buy @ $4.08, valued at $16.3k
02/08/2007 4 BOHLIN GAREN G (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Disposed/sold 4,000 options to buy @ $4.08, valued at $16.3k
02/08/2007 4 WAGNER RICHARD W (EVP, Discovery Research) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Unknown transaction of 4,048 shares @ $5, valued at $20.2k
Disposed/sold 49,999 options to buy @ $3.35, valued at $167.5k
02/08/2007 4 BAKER G LEONARD JR (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Unknown transaction of 30,441 shares @ $5, valued at $152.2k
Unknown transaction of 26,185 shares @ $5, valued at $130.9k
Unknown transaction of 1,420 shares @ $5, valued at $7.1k
Unknown transaction of 3,580 shares @ $5, valued at $17.9k
Unknown transaction of 286,547 shares @ $5, valued at $1.4M
Unknown transaction of 20,572 shares @ $5, valued at $102.9k
Unknown transaction of 14,675 shares @ $5, valued at $73.4k
Disposed/sold 4,000 options to buy @ $4.08, valued at $16.3k
02/08/2007 4 MCLAUGHLIN KEVIN F (President and CEO) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Unknown transaction of 45,000 shares @ $5, valued at $225k
Disposed/sold 80,000 options to buy @ $3.35, valued at $268k
02/08/2007 4 English Edward C (VP, CFO, Treasurer & Ass. Sec.) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Unknown transaction of 1,956 shares @ $5, valued at $9.8k
Disposed/sold 19,999 options to buy @ $3.35, valued at $67k
02/08/2007 4 GEFTER MALCOLM L PHD (Chairman and CSO) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Unknown transaction of 169,028 shares @ $5, valued at $845.1k
Unknown transaction of 1,300 shares @ $5, valued at $6.5k
02/07/2007 8-K Changes in Control of Registrant, Other Events, Financial Statements and Exhibits
02/02/2007 SC 13G DIMENSIONAL FUND ADVISORS INC reports a 6.5% stake in PRAECIS PHARMACEUTICALS INC
02/01/2007 8-K Acquisition/merger/asset purchase announced
Docs: "Asset Purchase Agreement, between PRAECIS PHARMACEUTICALS INCORPORATED and Speciality European Pharma Limited. †"
01/03/2007 SC 13D/A Engelberg Charles reports a 4.5% stake in PRAECIS PHARMACEUTICALS, INC.
12/21/2006 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Agreement and Plan of Merger, by and among SmithKline Beecham Corporation, Pilgrim Acquisition Corporation and PRAECIS PHARMACEUTICALS INCORPORATED",
"Amendment No. 1 to Rights Agreement, between PRAECIS PHARMACEUTICALS INCORPORATED and American Stock Transfer & Trust Company, as rights agent, amending the Rights Agreement, between PRAECIS PHARMACEUTICALS INCORPORATED and American Stock Transfer & Trust Company, as rights agent",
"GLAXOSMITHKLINE TO ACQUIRE PRAECIS PHARMACEUTICALS"
11/20/2006 SC 13D/A Efficacy Capital, Ltd. reports a 2.9% stake in PRAECIS PHARMACEUTICALS, INC.
11/16/2006 SC 13D/A Engelberg Charles reports a 5.3% stake in PRAECIS PHARMACEUTICALS, INC.
11/16/2006 SC 13D Engelberg Charles reports a 5.3% stake in PRAECIS PHARMACEUTICALS, INC.
11/09/2006 10-Q Quarterly Report for the period ended September 30, 2006
11/09/2006 8-K Quarterly results
Docs: "PRAECIS PHARMACEUTICALS INCORPORATED"
10/10/2006 SC 13D Efficacy Capital, Ltd. reports a 9.4% stake in PRAECIS PHARMACEUTICALS, INC.
09/05/2006 4 MCLAUGHLIN KEVIN F (President and CEO) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Exercised 24,200 shares @ $1.33, valued at $32.2k
Exercised 24,200 options to buy @ $0
08/04/2006 10-Q Quarterly Report for the period ended June 30, 2006
08/04/2006 8-K Quarterly results
Docs: "PRAECIS PHARMACEUTICALS INCORPORATED"
07/11/2006 4 GEFTER MALCOLM L PHD (Chairman and CSO) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 40,872 shares @ $3.01, valued at $123k
Exercised 92,500 options to buy @ $1.33, valued at $123k
06/21/2006 4 GARNICK MARC B (EVP and Chief Medical Officer) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns: Disposed/sold 13,999 options to buy @ $0
Granted 13,999 options to buy @ $0
Disposed/sold 19,999 options to buy @ $0
Granted 19,999 options to buy @ $0
06/20/2006 8-K Entry into a Material Definitive Agreement, Material Impairments, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Consulting and Termination Agreement and General Release",
"PRAECIS PHARMACEUTICALS INCORPORATED"
05/08/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "Letter sent by the Company to BusinessWeek Magazine on May 8, 2006"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy